Pedersen AK et al. |
Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha. |
1984 |
Thromb. Res. |
pmid:6546456
|
Cerskus AL et al. |
Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits. |
1978 |
Thromb. Res. |
pmid:653641
|
Ishikawa Y et al. |
Effect of cytoplasmic pH on platelet activation by arachidonic acid. |
1989 |
Thromb. Res. |
pmid:2499076
|
Gachályi B et al. |
In vitro effect of cimetidine on ADP induced platelet aggregation and thromboxane A2 synthesis in man. |
1984 |
Thromb. Res. |
pmid:6474407
|
Fitzpatrick F et al. |
Development of a gas chromatographic-mass spectrometric method using a stable isotope internal standard for quantitation of thromboxane B2. |
1984 |
Thromb. Res. |
pmid:6474413
|
Küster LJ et al. |
Mechanism of PAF-induced platelet aggregation in man. |
1986 |
Thromb. Res. |
pmid:3764802
|
Ali M et al. |
Synthesis of prostaglandin D2 and thromboxane B2 by human platelets. |
1977 |
Thromb. Res. |
pmid:918907
|
Reis F et al. |
The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. |
1999 |
Thromb. Res. |
pmid:10605951
|
Matsuo T et al. |
A new thrombin inhibitor MD805 and thrombocytopenia encountered with heparin hemodialysis. |
1986 |
Thromb. Res. |
pmid:3787568
|
Franconi F et al. |
Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro. |
2001 |
Thromb. Res. |
pmid:11369419
|
Ames PR et al. |
Aspirin insensitive thromboxane generation is associated with oxidative stress in type 2 diabetes mellitus. |
2012 |
Thromb. Res. |
pmid:22521214
|
Preston FE et al. |
Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man. |
1982 |
Thromb. Res. |
pmid:6815823
|
Weber AA et al. |
40 mg of aspirin are not sufficient to inhibit platelet function under conditions of limited compliance. |
2000 |
Thromb. Res. |
pmid:10709913
|
Altman R et al. |
Why single daily dose of aspirin may not prevent platelet aggregation. |
1988 |
Thromb. Res. |
pmid:3140408
|
Han P et al. |
Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide. |
1982 |
Thromb. Haemost. |
pmid:7101234
|
Miller KW and Keith JC |
Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension. |
1988 |
Thromb. Haemost. |
pmid:3238644
|
Teng CM et al. |
ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. |
1997 |
Thromb. Haemost. |
pmid:9066010
|
Santilli F et al. |
Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis. |
2013 |
Thromb. Haemost. |
pmid:24030807
|
Joseph S et al. |
Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore. |
1987 |
Thromb. Haemost. |
pmid:3110996
|
Pampolina C and McNicol A |
Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3. |
2005 |
Thromb. Haemost. |
pmid:15886812
|
Jilma-Stohlawetz P et al. |
Impaired platelet function among platelet donors. |
2001 |
Thromb. Haemost. |
pmid:11583322
|
Dejana E et al. |
Bleeding time in rats: a comparison of different experimental conditions. |
1982 |
Thromb. Haemost. |
pmid:6753230
|
Strano A et al. |
Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patients. |
1982 |
Thromb. Haemost. |
pmid:6753232
|
Hansen JB et al. |
The effect of lipopolysaccharides (LPS) on generation of thromboxane A2 and thromboplastin activity in whole blood of males, females and females on oral contraceptives. |
1989 |
Thromb. Haemost. |
pmid:2799762
|
Lepäntalo A et al. |
Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients. |
2006 |
Thromb. Haemost. |
pmid:16493486
|
Matsumoto M et al. |
Thromboxane generation in patients with essential hypertension or cerebrovascular disease and effect of oral aspirin. |
1980 |
Thromb. Haemost. |
pmid:7423441
|
Carter AJ et al. |
A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor. |
1984 |
Thromb. Haemost. |
pmid:6377567
|
Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Honey AC et al. |
Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit. |
1986 |
Thromb. Haemost. |
pmid:3775692
|
Krishnamurthi S et al. |
Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation. |
1982 |
Thromb. Haemost. |
pmid:6891107
|
Essien EM et al. |
Blood changes and enhanced thromboxane and 6-keto prostaglandin F1 alpha production in experimental acute Plasmodium bergei infection in hamsters. |
1984 |
Thromb. Haemost. |
pmid:6388013
|
Chen SL et al. |
Chlorobutanol, a preservative of desmopressin, inhibits human platelet aggregation and release in vitro. |
1990 |
Thromb. Haemost. |
pmid:2096493
|
Martinuzzo ME et al. |
Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. |
1993 |
Thromb. Haemost. |
pmid:8115993
|
Kyrle PA et al. |
Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin. |
1989 |
Thromb. Haemost. |
pmid:2508252
|
Stratta P et al. |
Warning: platelet factor 4, beta-thromboglobulin and thromboxane in donor's plasma units. |
1983 |
Thromb. Haemost. |
pmid:6189235
|
Scharf RE |
In vitro thromboxane synthesis of depleted blood platelets following renal transplantation. |
1990 |
Thromb. Haemost. |
pmid:2148845
|
Cattaneo M et al. |
Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium. |
1985 |
Thromb. Haemost. |
pmid:3927505
|
Wang WJ and Huang TF |
A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist. |
2001 |
Thromb. Haemost. |
pmid:11686327
|
Jackson C et al. |
DN 9693: a phosphodiesterase inhibitor with a platelet membrane effect. |
1989 |
Thromb. Haemost. |
pmid:2546286
|
Davì G et al. |
Increased thromboxane metabolites excretion in liver cirrhosis. |
1998 |
Thromb. Haemost. |
pmid:9569186
|
Sheu JR et al. |
Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. |
2000 |
Thromb. Haemost. |
pmid:10823277
|
Crescente M et al. |
Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings. |
2007 |
Thromb. Haemost. |
pmid:17549313
|
Landolfi R et al. |
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo". |
1994 |
Thromb. Haemost. |
pmid:7740468
|
Undas A et al. |
Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin. |
2007 |
Thromb. Haemost. |
pmid:17549314
|
Homoncik M et al. |
Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. |
2000 |
Thromb. Haemost. |
pmid:10739392
|
Perneby C et al. |
Dose- and time-dependent antiplatelet effects of aspirin. |
2006 |
Thromb. Haemost. |
pmid:16601836
|
Eldor A et al. |
Effects of dipyrone on prostaglandin production by human platelets and cultured bovine aortic endothelial cells. |
1983 |
Thromb. Haemost. |
pmid:6346571
|
Menys VC and Davies JA |
Selective inhibition of thromboxane synthetase with dazoxiben - basis of its inhibitory effect on platelet adhesion. |
1983 |
Thromb. Haemost. |
pmid:6346575
|
Foo LC et al. |
Platelets of habitual smokers have reduced susceptibility to aggregating agent. |
1991 |
Thromb. Haemost. |
pmid:2048056
|
Gordge MP et al. |
Platelet function and the bleeding time in progressive renal failure. |
1988 |
Thromb. Haemost. |
pmid:3187950
|
D'Angelo A et al. |
Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products. |
1983 |
Thromb. Haemost. |
pmid:6687766
|
Lessiani G et al. |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. |
2011 |
Thromb. Haemost. |
pmid:21103664
|
Greer IA et al. |
Platelet activation in allergic asthma. |
1985 |
Thromb. Haemost. |
pmid:2931855
|
Hohlfeld T et al. |
Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia. |
1994 |
Thromb. Haemost. |
pmid:7513092
|
Han P et al. |
Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation. |
1983 |
Thromb. Haemost. |
pmid:6415847
|
Turpeinen AM et al. |
Replacement of dietary saturated by unsaturated fatty acids: effects of platelet protein kinase C activity, urinary content of 2,3-dinor-TXB2 and in vitro platelet aggregation in healthy man. |
1998 |
Thromb. Haemost. |
pmid:9798986
|
Guthikonda S et al. |
Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. |
2008 |
Thromb. Haemost. |
pmid:18612542
|
Gresele P et al. |
Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests. |
1997 |
Thromb. Haemost. |
pmid:9423790
|
Naesh O et al. |
Platelet function in surgical stress. |
1985 |
Thromb. Haemost. |
pmid:2935969
|
Davì G et al. |
The effect of two low doses of aspirin on whole blood thromboxane and prostacyclin generation in healthy subjects. |
1983 |
Thromb. Haemost. |
pmid:6417815
|
Michelson AD et al. |
Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. |
1994 |
Thromb. Haemost. |
pmid:7522354
|
Dale J et al. |
The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism. |
1983 |
Thromb. Haemost. |
pmid:6689091
|
Hornby EJ et al. |
The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion. |
1989 |
Thromb. Haemost. |
pmid:2529661
|
Bar J et al. |
The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia. |
1997 |
Thromb. Haemost. |
pmid:9364994
|
Husted SE et al. |
Intravenous acetylsalicylic acid--dose-related effects on platelet function and fibrinolysis in healthy males. |
1992 |
Thromb. Haemost. |
pmid:1412171
|
Subbiah MT et al. |
Studies of aggregation and thromboxane B2 synthesis in avian thrombocytes: comparison between atherosclerosis-susceptible and resistant breeds. |
1980 |
Thromb. Haemost. |
pmid:7455983
|
Zahavi M et al. |
Abnormal typical pattern of platelet function and thromboxane generation in unstable angina. |
1989 |
Thromb. Haemost. |
pmid:2531938
|
Barrett PA and Butler KD |
Shortening of platelet survival by induced hypercholesterolaemia in rabbits and its prolongation by anagrelide. |
1983 |
Thromb. Haemost. |
pmid:6648889
|
Cortellaro M et al. |
Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis-effect of sulphinpyrazone treatment. |
1983 |
Thromb. Haemost. |
pmid:6665767
|
Szczeklik A et al. |
Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. |
1986 |
Thromb. Haemost. |
pmid:3563961
|
Falcon CR et al. |
The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionized calcium. |
1993 |
Thromb. Haemost. |
pmid:8259535
|
Larsen SB et al. |
Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction. |
2012 |
Thromb. Haemost. |
pmid:22534977
|
Cattaneo M et al. |
Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway. |
1988 |
Thromb. Haemost. |
pmid:3146144
|
Fimognari FL et al. |
Nocturnal rise of urinary thromboxane B 2 in patients with coronary artery disease. |
2005 |
Thromb. Haemost. |
pmid:15735822
|
De Caterina R et al. |
Organic nitrates: direct antiplatelet effects and synergism with prostacyclin. Antiplatelet effects of organic nitrates. |
1988 |
Thromb. Haemost. |
pmid:3291182
|
Teng CM and Ko FN |
Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. |
1988 |
Thromb. Haemost. |
pmid:3291184
|
de Castellarnau C et al. |
Prostacyclin and thromboxane production by autogenous femoral veins grafted into the arterial circulation of the dog. |
1989 |
Thromb. Haemost. |
pmid:2665174
|
Davì G et al. |
Demonstration of Rickettsia Conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever. |
1995 |
Thromb. Haemost. |
pmid:8584998
|
Habib A et al. |
Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies. |
1995 |
Thromb. Haemost. |
pmid:8585020
|
Evangelista V et al. |
Defibrotide inhibits platelet activation by cathepsin G released from stimulated polymorphonuclear leukocytes. |
1992 |
Thromb. Haemost. |
pmid:1509406
|
Rocca B et al. |
Increased thromboxane biosynthesis in essential thrombocythemia. |
1995 |
Thromb. Haemost. |
pmid:8607099
|
Korbut R et al. |
On the mechanism of thrombolytic action of thromboxane synthetase inhibitors. |
1987 |
Thromb. Haemost. |
pmid:3324381
|
Huang TF et al. |
Mechanism of action of a potent antiplatelet peptide, triflavin from Trimeresurus flavoviridis snake venom. |
1991 |
Thromb. Haemost. |
pmid:1665595
|
Totani L et al. |
Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse. |
2012 |
Thromb. Haemost. |
pmid:22436970
|
Véricel E et al. |
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. |
2015 |
Thromb. Haemost. |
pmid:25832443
|
Spowart K et al. |
Haemostatic effects of ketorolac with and without concomitant heparin in normal volunteers. |
1988 |
Thromb. Haemost. |
pmid:3266379
|
Cerletti C et al. |
Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma". |
1985 |
Thromb. Haemost. |
pmid:4049312
|
Aoki T et al. |
Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. |
1998 |
Thromb. Haemost. |
pmid:9657446
|
Dotevall A et al. |
Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females. |
1992 |
Thromb. Haemost. |
pmid:1455405
|
De Caterina R et al. |
Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin. |
1991 |
Thromb. Haemost. |
pmid:1871711
|
de Boer A et al. |
Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers. |
1991 |
Thromb. Haemost. |
pmid:1722918
|
Davì G et al. |
Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. |
1996 |
Thromb. Haemost. |
pmid:8819248
|
Ding YA et al. |
Potentiation of adrenaline-induced platelet aggregation by angiotensin II. |
1985 |
Thromb. Haemost. |
pmid:4089801
|
Blais N et al. |
Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). |
2009 |
Thromb. Haemost. |
pmid:19652893
|
Forastiero R et al. |
Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. |
1998 |
Thromb. Haemost. |
pmid:9459320
|
Holme S et al. |
The effect of albumin bound polyunsaturated fatty acids on human platelets. |
1984 |
Thromb. Haemost. |
pmid:6719386
|
Carter AJ and Hanley SP |
The effect of platelet number and haematocrit on whole blood thromboxane synthesis. |
1985 |
Thromb. Haemost. |
pmid:4024033
|
Brox JH et al. |
The effect of cod liver oil and corn oil on platelets and vessel wall in man. |
1981 |
Thromb. Haemost. |
pmid:7031981
|
Strano A et al. |
Thromboxane formation by platelets and platelet sensitivity to prostacyclin in patients with acute myocardial infarction. |
1981 |
Thromb. Haemost. |
pmid:7036402
|
Butler KD et al. |
The effects of modulation of prostanoid metabolism on the thoracic platelet accumulation induced by intravenous administration of collagen in the guinea-pig. |
1986 |
Thromb. Haemost. |
pmid:3105104
|